drugset / Trial / NCT01703884

ANC & Malaria Diagnostic in Pregnancy

NCT01703884 ↗

Phase 4 Completed 5254 enrolled Centre Muraz World Health Organization · collab
RandomizedParallel-groupOpen-labelPrevention

Summary

The program's overall objective is to assess the impact of a package of interventions aimed at reducing malaria-related mortality and morbidity in pregnant women and newborns by ensuring access to a package of interventions designed to optimise the detection and treatment of malaria during pregnancy as well as improving the early detection and treatment of malaria during the third trimester.

Timeline

Start
2012-08
Primary completion
2014-07
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject ASAQ Unknown — —

Indications